Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-02

Clinical Trial Update: Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients [NA]

View source ↗

Summary

A terminated clinical trial evaluating an oral nutritional supplement in lung cancer patients to address cancer cachexia, reporting safety, tolerability, and ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral Nutritional Supplement

Snippet

Sponsor: Fresenius Kabi | Conditions: Cachexia, Cancer | NA | Status: TERMINATED